Drugs News and Research

RSS

Japanese PAH patient prognosis ‘good’

Japanese patients respond well to pulmonary arterial hypertension-targeted drugs and may have a good prognosis with long-term survival, study findings suggest.

13 Mar 2014

TFDA approves TaiGen's Taigexyn NDA for treatment of community-acquired bacterial pneumonia

TaiGen Biotechnology Company, Limited today announced that the Taiwan Food and Drug Administration has approved the new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn.

13 Mar 2014

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

PhotoMedex, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Aradigm Corporation (the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2013.

13 Mar 2014

Patient with advanced bladder cancer shows complete response to everolimus and pazopanib drugs

A patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination everolimus and pazopanib in a phase I trial, and genomic profiling of his tumor revealed two alterations that may have caused this exceptional response, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

13 Mar 2014

Highlights: No-bid contract decision in Calif.; Fla. hospital Medicaid settlement; navigator restrictions in Kan.

A selection of health policy stories from California, Florida, Kansas, New York, Virginia, Maryland, Wisconsin and Minnesota.

13 Mar 2014

New research raises hopes of new class of drugs to combat antibiotic resistant infections

New research has found some compounds effective in blocking the proliferation of certain bacteria, raising hopes of a new class of drugs to combat antibiotic resistant infections

13 Mar 2014

Investigators urge drug regulators to provide clear evidence on statins’ side effects

At a time when the wider prescription of statins is under renewed public scrutiny, a substantial analysis of placebo-controlled randomised trials of statins has found that only a small minority of side effects reported by those taking the cholesterol-lowering drugs are actually attributable to them.

13 Mar 2014

Quintiles prices secondary public offering of 15M shares of common stock

Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share.

13 Mar 2014

People with prehypertension more likely to develop stroke

Anyone with blood pressure that's higher than the optimal 120/80 mmHg may be more likely to have a stroke, according to a new meta-analysis published in the March 12, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

13 Mar 2014

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

Although community network studies show that sexual relationships occur between members of "risk groups" -- men who have sex with other men (MSM), people who inject drugs (PWID), non-injection drug users (NIDU) -- and heterosexuals, researchers at New York University's Center for Drug Use and HIV Research (CDUHR) note that little research has been done to help explain how HIV epidemics and programs in one population affect others and how to reduce the risks of transmission.

13 Mar 2014

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine.

13 Mar 2014

Hepatitis C drug fuels cost debate

A panel of experts said this week that the drug represents a "low value" to the health system because of its cost.

13 Mar 2014

First Edition: March 12, 2014

Today's headlines include stories about the Obama administration's latest tallies regarding how many Americans have signed up for Obamacare coverage and the outcome of a Florida special election that was marked by health law themes.

12 Mar 2014

EPFL sets up foundation to release antibiotic for tuberculosis

Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.

12 Mar 2014

N30 Pharma begins oral dosing in N91115 Phase 1 trial for treatment of cystic fibrosis

N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).

12 Mar 2014

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Quintiles last night was named the "Best CRO in Asia" at the 2014 BioPharma Asia Industry Awards dinner, the third time in the event's four-year history that Quintiles has received the honor.

12 Mar 2014

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.

12 Mar 2014

Three innovative tools to detect, test and initiate personalized drug treatment for seizures

A team of researchers from the National Institutes of Health, Emory University and Cedars-Sinai - specialists in identifying and treating very rare diseases - used three innovative tools to detect a previously unknown gene mutation, test potential therapies in the lab, and initiate personalized drug treatment for a boy with a lifelong history of uncontrollable seizures that caused significant impact on his cognitive and social development.

12 Mar 2014

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Now that the badly botched rollout of the federal government's health care website seems to be behind us, Republicans have shifted their criticisms to several states that are experiencing problems enrolling people on their state-run exchanges.

12 Mar 2014

Drugs News and Research

Japanese PAH patient prognosis ‘good’

TFDA approves TaiGen's Taigexyn NDA for treatment of community-acquired bacterial pneumonia

PhotoMedex Q4 2013 revenues up 16% to $63.5 million

Aradigm reports record revenue of $4.6M in fourth quarter 2013

Patient with advanced bladder cancer shows complete response to everolimus and pazopanib drugs

Highlights: No-bid contract decision in Calif.; Fla. hospital Medicaid settlement; navigator restrictions in Kan.

New research raises hopes of new class of drugs to combat antibiotic resistant infections

Investigators urge drug regulators to provide clear evidence on statins’ side effects

Quintiles prices secondary public offering of 15M shares of common stock

People with prehypertension more likely to develop stroke

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Hepatitis C drug fuels cost debate

First Edition: March 12, 2014

EPFL sets up foundation to release antibiotic for tuberculosis

N30 Pharma begins oral dosing in N91115 Phase 1 trial for treatment of cystic fibrosis

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Three innovative tools to detect, test and initiate personalized drug treatment for seizures

Viewpoints: Exploiting botched exchanges; falling number of uninsured; Medicare drug plan retreat

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News